← FDA DRUG APPROVALS

FDA ANDA · ANDA074147

METOCLOPRAMIDE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA074147
TYPE
ANDA
ORIGINAL APPROVAL
1996-08-02
LATEST ACTION
2002-12-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE HYDROCHLORIDEDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML · INJECTABLE · INJECTION

Approval history

2002-12-06Labeling · Supplement 6AP
2002-02-01Labeling · Supplement 4AP
2001-02-14Manufacturing (CMC) · Supplement 3AP
2000-04-06Labeling · Supplement 2AP
1999-10-22Labeling · Supplement 1AP
1996-08-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →